Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
to compare the efficacy of FluCam versus fludarabine phosphate alone based on the median time to disease progression (TTP) for the 2 treatment groups
Critère d'inclusion
- Second line therapy with fludara plus Alentuzumab (Mabcampath) in Patient with b-cell Chronic Lymphocytic Leukemia,terapia di seconda linea in associazione Fludara con alentuzumab (Mabcampth) per il trattamento di pazienti affetti da Leucemia Linfocitica Cronica delle cellule B